Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 3
2000 4
2001 6
2003 1
2004 1
2005 3
2006 2
2007 2
2008 6
2009 6
2010 2
2011 2
2012 2
2014 1
2015 1
2018 1
2020 1
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities.
Davis KD, Aghaeepour N, Ahn AH, Angst MS, Borsook D, Brenton A, Burczynski ME, Crean C, Edwards R, Gaudilliere B, Hergenroeder GW, Iadarola MJ, Iyengar S, Jiang Y, Kong JT, Mackey S, Saab CY, Sang CN, Scholz J, Segerdahl M, Tracey I, Veasley C, Wang J, Wager TD, Wasan AD, Pelleymounter MA. Davis KD, et al. Among authors: burczynski me. Nat Rev Neurol. 2020 Jul;16(7):381-400. doi: 10.1038/s41582-020-0362-2. Epub 2020 Jun 15. Nat Rev Neurol. 2020. PMID: 32541893 Free PMC article. Review.
Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact.
Goodsaid FM, Amur S, Aubrecht J, Burczynski ME, Carl K, Catalano J, Charlab R, Close S, Cornu-Artis C, Essioux L, Fornace AJ Jr, Hinman L, Hong H, Hunt I, Jacobson-Kram D, Jawaid A, Laurie D, Lesko L, Li HH, Lindpaintner K, Mayne J, Morrow P, Papaluca-Amati M, Robison TW, Roth J, Schuppe-Koistinen I, Shi L, Spleiss O, Tong W, Truter SL, Vonderscher J, Westelinck A, Zhang L, Zineh I. Goodsaid FM, et al. Among authors: burczynski me. Nat Rev Drug Discov. 2010 Jun;9(6):435-45. doi: 10.1038/nrd3116. Nat Rev Drug Discov. 2010. PMID: 20514070 Review.
Biomarkers in the pharmaceutical industry.
Laterza OF, Plump A, Ming JE, Richards S, Burczynski ME, Wagner JA, Patterson SD. Laterza OF, et al. Among authors: burczynski me. Clin Chem. 2015 Apr;61(4):579-83. doi: 10.1373/clinchem.2014.225284. Epub 2014 Nov 6. Clin Chem. 2015. PMID: 25376580 No abstract available.
Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy.
Coughlin CM, Johnston DS, Strahs A, Burczynski ME, Bacus S, Hill J, Feingold JM, Zacharchuk C, Berkenblit A. Coughlin CM, et al. Among authors: burczynski me. Breast Cancer Res Treat. 2010 Nov;124(1):1-11. doi: 10.1007/s10549-010-1108-4. Epub 2010 Aug 28. Breast Cancer Res Treat. 2010. PMID: 20803067 Review.
Use of ex vivo systems for biomarker discovery.
Lavallie ER, Dorner AJ, Burczynski ME. Lavallie ER, et al. Among authors: burczynski me. Curr Opin Pharmacol. 2008 Oct;8(5):647-53. doi: 10.1016/j.coph.2008.08.003. Epub 2008 Sep 19. Curr Opin Pharmacol. 2008. PMID: 18771752 Review.
45 results